Upland Software program (UPLD) Lags Q2 Earnings Estimates

HomeInvesting

Upland Software program (UPLD) Lags Q2 Earnings Estimates


Upland Software program (UPLD) got here out with quarterly earnings of $0.41 per share, lacking the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.60 per share a 12 months in the past. These figures are adjusted for non-recurring objects.

This quarterly report represents an earnings shock of -2.38%. 1 / 4 in the past, it was anticipated that this maker of cloud-based enterprise work-management software program would publish earnings of $0.41 per share when it truly produced earnings of $0.60, delivering a shock of 46.34%.

During the last 4 quarters, the corporate has surpassed consensus EPS estimates 3 times.

Upland Software program, which belongs to the Zacks Web – Software program trade, posted revenues of $76.26 million for the quarter ended June 2021, surpassing the Zacks Consensus Estimate by 1.51%. This compares to year-ago revenues of $71.32 million. The corporate has topped consensus income estimates 4 instances during the last 4 quarters.

The sustainability of the inventory’s fast worth motion based mostly on the recently-released numbers and future earnings expectations will largely rely on administration’s commentary on the earnings name.

Upland Software program shares have misplaced about 23.7% because the starting of the 12 months versus the S&P 500’s acquire of 17.8%.

What’s Subsequent for Upland Software program?

Whereas Upland Software program has underperformed the market up to now this 12 months, the query that involves traders’ minds is: what’s subsequent for the inventory?

There are not any straightforward solutions to this key query, however one dependable measure that may assist traders handle that is the corporate’s earnings outlook. Not solely does this embrace present consensus earnings expectations for the approaching quarter(s), but in addition how these expectations have modified recently.

Empirical analysis exhibits a powerful correlation between near-term inventory actions and developments in earnings estimate revisions. Traders can monitor such revisions by themselves or depend on a tried-and-tested ranking instrument just like the Zacks Rank, which has a powerful monitor document of harnessing the facility of earnings estimate revisions.

Forward of this earnings launch, the estimate revisions development for Upland Software program was blended. Whereas the magnitude and route of estimate revisions might change following the corporate’s just-released earnings report, the present standing interprets right into a Zacks Rank #3 (Maintain) for the inventory. So, the shares are anticipated to carry out in keeping with the market within the close to future. You’ll be able to see the whole listing of right now’s Zacks #1 Rank (Robust Purchase) shares right here.

It will likely be attention-grabbing to see how estimates for the approaching quarters and present fiscal 12 months change within the days forward. The present consensus EPS estimate is $0.48 on $77.24 million in revenues for the approaching quarter and $2.04 on $307.1 million in revenues for the present fiscal 12 months.

Traders needs to be aware of the truth that the outlook for the trade can have a cloth impression on the efficiency of the inventory as properly. When it comes to the Zacks Business Rank, Web – Software program is presently within the backside 27% of the 250 plus Zacks industries. Our analysis exhibits that the highest 50% of the Zacks-ranked industries outperform the underside 50% by an element of greater than 2 to 1.

Breakout Biotech Shares with Triple-Digit Revenue Potential

The biotech sector is projected to surge past $775 billion by 2024 as scientists develop therapies for hundreds of illnesses. They’re additionally discovering methods to edit the human genome to actually erase our vulnerability to those illnesses.

Zacks has simply launched Century of Biology: 7 Biotech Shares to Purchase Proper Now to assist traders revenue from 7 shares poised for outperformance. Our current biotech suggestions have produced positive factors of +50%, +83% and +164% in as little as 2 months. The shares on this report might carry out even higher.

See these 7 breakthrough shares now>>

Click on to get this free report

Upland Software program, Inc. (UPLD): Free Inventory Evaluation Report

To learn this text on Zacks.com click on right here.

Zacks Funding Analysis

The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.



www.nasdaq.com